M Andres Blanco

6PUBLICATIONS

52CO-AUTHORS

Predictive and prognostic markersMolecular targetsRegenerative medicine (incl. stem cells)Innate immunity

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jun 17, 2026

In vivo CRISPR knockout screen identifies Polr1a as a key driver and a potential therapeutic target for melanoma metastasis.

|Feb 17, 2026

Recruitment of BRD4 to the ASXL1 genomic targets depends on the extra-terminal domain of BRD4.

Karthik Selvam, Shuang Lu, Clémence Messmer

|Nov 26, 2025

Combinatorial inhibition of LSD1 and Menin induces therapeutic differentiation in AML.

María F Carrera Rodríguez, Joshua Rico, Manaswini Vijayaraghavan

|Nov 11, 2025

Forward genetic screening in engineered colorectal cancer organoids identifies regulators of metastasis.

Xin Wang, Zvi Cramer, Nicolae Adrian Leu

|Apr 16, 2025

Perturbing LSD1 and WNT rewires transcription to synergistically induce AML differentiation.

Amir Hosseini, Abhinav Dhall, Nemo Ikonen

|Oct 18, 2022

Protection of Regulatory T Cells from Fragility and Inactivation in the Tumor Microenvironment.

Hongru Zhang, Vivek S Tomar, Jinyang Li

Pageof 1

Frequent Collaborators

Serge Y Fuchs

Hongru Zhang

Vivek S Tomar

Jinyang Li

Raghavendra Basavaraja

Fangxue Yan

Jun Gui

Noreen McBrearty

Tara Lee Costich

Daniel P Beiting

Frequent Collaborators

Serge Y Fuchs

Hongru Zhang

Vivek S Tomar

Jinyang Li